Modelling T-cell function ex vivo, we observed a reduction in T-cell activation markers, CD44 and CD107a, on effector T-cells cultured in supernatant from human and murine B-ALL cell lines. This evidence concerns the gene LAMP1 and acute lymphoblastic leukemia.